Research
Hormonal
GLP-1-RAs are known to delay gastric emptying.
Understanding the effect of GLP-1-RAs on gastric emptying is crucial for perioperative management.
StrongSupportsmedium confidence
GLP-1-RAs are known to delay gastric emptying.
Why this rating
This is a well-established mechanism in the literature.
Source
Perioperative management of patients on glucagon-like peptide-1 receptor agonists
Glenio B. Mizubuti et al. · Current Opinion in Anaesthesiology · 2024
DOI 10.1097/aco.0000000000001348
reviewCited 27×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →